226. Dr. Daisy Robinton, Co-founder & CEO of Oviva Therapeutics
Today, I'm joined by Dr. Daisy Robinton, co-founder & CEO of Oviva Therapeutics.
Daisy is a Harvard-trained molecular biologist on a mission to extend female healthspan. Targeting ovarian function as a lever for longevity, Oviva hopes to make menopause optional.
In this episode, we discuss how Oviva Therapeutics plans to deliver additional years of vibrant living to women. Plus, we talk about the intersection of biology and longevity.
We also cover:
• The future of women's health
• How lifestyle interventions impact aging
• Oviva's process for developing novel therapeutics
Subscribe to the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.